Table 3 Relation between protein co-expression and clinicopathological parameters n (%)
Parameter | Case | S100A4 expression/serum CA19.9 level | ρ | P value | |||
|---|---|---|---|---|---|---|---|
(+)/(+) | (+)/(−) | (−)/(+) | (−)/(−) | ||||
Differentiation | − 0.280 | 0.001 | |||||
High | 36 (28.1) | 18 (14.1) | 4 (3.1) | 8 (6.3) | 6 (4.7) | ||
Middle-low | 92 (71.9) | 71 (55.5) | 3 (2.3) | 17 (13.3) | 1 (0.8) | ||
TNM stage | − 0.389 | 0.000 | |||||
I–II | 58 (45.3) | 30 (23.4) | 2 (1.6) | 19 (14.8) | 7 (5.5) | ||
III–IV | 70 (54.7) | 59 (46.1) | 5 (3.9) | 6 (4.7) | 0 (0) | ||
Lymph node metastasis | 0.254 | 0.008 | |||||
Present | 66 (51.6) | 53 (41.4) | 2 (1.6) | 11 (8.6) | 0 (0) | ||
Absent | 62 (48.4) | 36 (28.1) | 5 (3.9) | 14 (10.9) | 7 (5.5) | ||
Case | 128 (100) | 89 (69.5) | 7 (5.5) | 25 (19.5) | 7 (5.5) | ||